CollPlant Biotechnologies Ltd. (CLGN)

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $10.62M in the twelve months ending March 31, 2024, with 1,495.20% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $98.00K, a -77.37% decrease year-over-year. In the year 2023, CollPlant Biotechnologies had annual revenue of $10.96M with 3,565.22% growth.

• Revenue (ttm): $10.62M
• Revenue Growth: +1,495.20%
• P/S Ratio: 5.35
• Revenue / Employee: $141,653
• Employees: 75
• Market Cap: 56.81M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	10.96M	10.66M	3,565.22%
Dec 31, 2022	299.00K	-15.34M	-98.09%
Dec 31, 2021	15.64M	9.50M	154.86%
Dec 31, 2020	6.14M	3.82M	164.75%
Dec 31, 2019	2.32M	-2.70M	-53.77%
Dec 31, 2018	5.01M	4.55M	982.94%
Dec 31, 2017	463.00K	381.82K	470.37%
Dec 31, 2016	81.18K	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.